A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism
Qiang Wang(Jianghan University), Zifu Li(Huazhong University of Science and Technology), Tian Yang(Second Military Medical University), Ao Hua(Huazhong University of Science and Technology), Shiyou Li(Stephen F. Austin State University), Zeyang Ding(Huazhong University of Science and Technology), Bixiang Zhang(Ministry of Education of the People's Republic of China), Xiang Chen(Microsoft (United States)), Chong Wang(Children's Hospital of Chongqing Medical University), Chen Xu(Second Military Medical University), Jiangling Wan(Huazhong University of Science and Technology), Yuxuan Xiong(Huazhong University of Science and Technology), Qingyuan Deng(Huazhong University of Science and Technology), Xiangliang Yang(Wuhan National Laboratory for Optoelectronics)
Cited by 27
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
|Nature Communications|2019|803